DeepMed Research

MEDTRONIC DIABETES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

Not Applicable

Recruiting

Conditions: Type I Diabetes

First Posted Date: 2024-12-18

Last Posted Date: 2025-04-08

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 40

Registration Number: NCT06739811

Locations: 🇳🇱
Isala Zwolle, Zwolle, Netherlands

SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes

Not Applicable

Not yet recruiting

Conditions: Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

First Posted Date: 2024-12-06

Last Posted Date: 2025-01-10

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 1500

Registration Number: NCT06719531

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Northwell Health, New Hyde Park, New York, United States

and more 25 locations

Smart MDI Study (CIP343)

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 1

First Posted Date: 2024-10-17

Last Posted Date: 2025-03-25

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 140

Registration Number: NCT06645834

Locations: 🇧🇪
Antwerp University Hospital, Antwerpen, Belgium
🇧🇪
Hospital Universitaire Bruxelles Erasme, Brussels, Belgium
🇧🇪
UZ Leuven, Leuven, Belgium

and more 15 locations

Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

Not Applicable

Recruiting

Conditions: Type 1 Diabetes

Interventions: Device: Insulin Pump with Continuous Glucose Monitoring

First Posted Date: 2024-09-20

Last Posted Date: 2025-05-08

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 60

Registration Number: NCT06604871

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
UCSF The Madison Clinic for Pediatric Diabetes, San Francisco, California, United States
🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States

and more 5 locations

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Insulin Pump with Continuous Glucose Monitoring

First Posted Date: 2023-02-06

Last Posted Date: 2025-02-17

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 250

Registration Number: NCT05714059

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Childrens Hospital and Clinics of Minnesota, Saint Paul, Minnesota, United States
🇺🇸
AM Diabetes and Endocrinology Center, Bartlett, Tennessee, United States

and more 20 locations

Evaluation of the MiniMed 780 System in Paediatric Subjects

Not Applicable

Completed

Conditions: Diabetes Type1
Children, Only

Interventions: Device: Continuation Phase MiniMed 780G Auto Mode with G4S sensor

First Posted Date: 2022-10-10

Last Posted Date: 2024-12-27

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 101

Registration Number: NCT05574062

Locations: 🇫🇮
Tampere University Hospital, Tampere, Finland
🇸🇮
University Medical Center Ljubljana (UMCL), Ljubljana, Slovenia
🇫🇮
Turku University Hospital, Turku, Finland

and more 9 locations

Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: MiniMed 780G System

First Posted Date: 2022-04-13

Last Posted Date: 2025-01-15

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 244

Registration Number: NCT05325294

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
East Coast Institute for Research (Memorial Hospital), Jacksonville, Florida, United States
🇺🇸
Endocrine Research Solutions, Roswell, Georgia, United States

and more 16 locations

In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes Treated With Insulin

Interventions: Device: MiniMed™ 780G Insulin Pump system

First Posted Date: 2022-02-14

Last Posted Date: 2025-02-21

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 574

Registration Number: NCT05238142

Locations: 🇺🇸
Medical Investigations, Little Rock, Arkansas, United States
🇺🇸
Headlands Research California LLC, Escondido, California, United States
🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States

and more 25 locations

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: MiniMed 780G System

First Posted Date: 2022-02-04

Last Posted Date: 2024-06-27

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 240

Registration Number: NCT05224258

Locations: 🇺🇸
Rady's Children's Hospital, San Diego, California, United States
🇺🇸
Atlanta Diabetes Associates, Atlanta, Georgia, United States
🇺🇸
The Docs, LLC, Las Vegas, Nevada, United States

and more 15 locations

InPen User Experience

Not Applicable

Completed

Conditions: Diabetes Type 1

Interventions: Device: InPen with Guardian 4 System

First Posted Date: 2021-08-31

Last Posted Date: 2024-01-10

Lead Sponsor: Medtronic Diabetes

Target Recruit Count: 34

Registration Number: NCT05029271

Locations: 🇸🇪
Örebro University Hospital, Örebro, Sweden
🇸🇪
NU-Hospital Group, Uddevalla, Sweden
🇸🇪
Frolunda specialist hospital, Vastra Frolunda, Sweden

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy